World Health Organization Raises Alert Over Severe Lack of Weight-Loss Injections

Under one in 10 patients who could benefit from obesity jabs including Wegovy are able to get them, caution the World Health Organization as it issues its first guidance on the medications.

With over a billion individuals worldwide currently classified as obese, it is calling for broader and more equitable availability to these injectable treatments.

Per projections, in excess of 2,000,000,000 will be obese by 2030 if no action is taken.

"The latest guidance affirms that excess weight is a chronic disease that can be managed with comprehensive and continuous treatment," remarked its chief Tedros Adhanom Ghebreyesus.

Significant expense, limited production capacity, and distribution challenges are key obstacles to universal availability to the jabs that can assist patients in reducing substantial weight, says the organization.

Weight-Loss Drug Supply Crisis

Even under the current most optimistic case, the manufacturing of these medications might only reach about 100 million people – fewer than 10% of eligible patients, per the WHO.

The recommendation encourages countries and companies to widen availability, by measures like patent sharing.

The intellectual property rights on semaglutide – the core component of Novo Nordisk's Wegovy – is set to lapse in a number of nations in 2026.

The Way Weight-Loss Jabs Operate

GLP-1 drugs replicate a biological compound to slow digestion, curb appetite and enhance the sense of being full so people consume fewer calories.

Patients commonly start to lose weight after several weeks of starting on the regular doses.

Research suggests patients may regain a significant portion within a year of stopping the treatment, because their usual appetite come back.

Being carrying excess weight increases your risk for developing diseases, including type 2 diabetes, cardiovascular issues, stroke, and some malignancies.

Obesity concerns individuals in countries worldwide and was linked to millions of fatalities worldwide in 2024, as per the health agency.